Journal article
Authors list: Azoitei, Ninel; Kleger, Alexander; Schoo, Nina; Thal, Dietmar Rudolf; Brunner, Cornelia; Pusapati, Ganesh Varma; Filatova, Alina; Genze, Felicitas; Moeller, Peter; Acker, Til; Kuefer, Rainer; Van Lint, Johan; Baust, Heinrich; Adler, Guido; Seufferlein, Thomas
Publication year: 2011
Pages: 710-724
Journal: Neuro-Oncology
Volume number: 13
Issue number: 7
ISSN: 1522-8517
eISSN: 1523-5866
Open access status: Green
DOI Link: https://doi.org/10.1093/neuonc/nor084
Publisher: Oxford University Press
Abstract:
Glioblastoma multiforme, a highly aggressive tumor of the central nervous system, has a dismal prognosis that is due in part to its resistance to radio- and chemotherapy. The protein kinase C (PKC) family of serine threonine kinases has been implicated in the formation and proliferation of glioblastoma multiforme. Members of the protein kinase D (PKD) family, which consists of PKD1, -2 and, -3, are prominent downstream targets of PKCs and could play a major role in glioblastoma growth. PKD2 was highly expressed in both low-grade and high-grade human gliomas. The number of PKD2-positive tumor cells increased with glioma grading (P < .001). PKD2 was also expressed in CD133-positive glioblastoma stem cells and various glioblastoma cell lines in which the kinase was found to be constitutively active. Inhibition of PKDs by pharmacological inhibitors resulted in substantial inhibition of glioblastoma proliferation. Furthermore, specific depletion of PKD2 by siRNA resulted in a marked inhibition of anchorage-dependent and -independent proliferation and an accumulation of glioblastoma cells in G0/G1, accompanied by a down-regulation of cyclin D1 expression. In addition, PKD2-depleted glioblastoma cells exhibited substantially reduced tumor formation in vivo on chicken chorioallantoic membranes. These findings identify PKD2 as a novel mediator of glioblastoma cell growth in vitro and in vivo and thereby as a potential therapeutic target for this devastating disease.
Citation Styles
Harvard Citation style: Azoitei, N., Kleger, A., Schoo, N., Thal, D., Brunner, C., Pusapati, G., et al. (2011) Protein kinase D2 is a novel regulator of glioblastoma growth and tumor formation, Neuro-Oncology, 13(7), pp. 710-724. https://doi.org/10.1093/neuonc/nor084
APA Citation style: Azoitei, N., Kleger, A., Schoo, N., Thal, D., Brunner, C., Pusapati, G., Filatova, A., Genze, F., Moeller, P., Acker, T., Kuefer, R., Van Lint, J., Baust, H., Adler, G., & Seufferlein, T. (2011). Protein kinase D2 is a novel regulator of glioblastoma growth and tumor formation. Neuro-Oncology. 13(7), 710-724. https://doi.org/10.1093/neuonc/nor084
Keywords
C-MU; D1; D FAMILY; glioblastoma multiforme; ONCOGENE; PKD2; protein kinase D2